The Keystone Program in Personalized Risk and Prevention

Mary B. Daly, M.D., Ph.D., F.A.C.P.
Leader, Keystone Program in Personalized Risk and Prevention

Dr. Mary B. Daly is Chair of the Department of Clinical Genetics at Fox Chase Cancer Center. A senior member of the staff, she holds the Timothy R. Talbot Jr. Chair in Cancer Research, named for the first Fox Chase president. Daly oversees Fox Chase programs in behavioral research, human genetics, epidemiologic research and cancer prevention research. An epidemiologist and board-certified medical oncologist specializing in breast and ovarian cancers, Daly is renowned for her work in developing evidence-based interventions for cancer-risk education, risk counseling, risk communication and behavior modification. She established Fox Chase’s Margaret Dyson Family Risk Assessment Program for women at increased risk of breast or ovarian cancer—a prevention and early-detection program that was among the first of its kind and the only one in the region when it opened in 1991. Daly has received numerous awards, including the American Cancer Society Cancer Control Award in 1996 and 2004 and the John Peter Minton, M.D., Ph.D., Memorial Lectureship at Ohio State’s James Cancer Center. Daly joined Fox Chase in 1989. She has served on several national and international scientific committees, including the Board of Scientific Advisors to the National Cancer Institute, the Human Genome Cancer Studies Consortium and the Observational Study Monitoring Board for the Women’s Health Initiative. She is a past president of the American Society of Preventive Oncology. Daly earned her B.A. in biology at New York’s College of New Rochelle and her M.S.P.H. and Ph.D. in epidemiology and M.D. from the University of North Carolina at Chapel Hill. She received all her postdoctoral medical training at the University of Texas Health Science Center in San Antonio.